U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 19

1.

MiRNA expression profiling in pancreatic ductal adenocarcinoma (PDAC) cells treated with TGF-b

(Submitter supplied) Expression profiling of 2555 miRNAs was performed using microarray. Of these, 1719 miRNAs expressed in PDAC cells.
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by array
Platform:
GPL21263
6 Samples
Download data: TXT
Series
Accession:
GSE121369
ID:
200121369
2.

MiRNA expression profiling in cholangiocarcinoma (CCA) cells treated with TGF-b

(Submitter supplied) Expression profiling of 2555 miRNAs was performed using microarray. Of these, 451 miRNAs expressed in CCA cells. Microarray identified 17 miRNAs that were increased by > 1.5-fold and 56 miRNAs that were decreased by < 0.67-fold in CCA cells treated with TGF-β.
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by array
Platform:
GPL18941
6 Samples
Download data: TXT
Series
Accession:
GSE104629
ID:
200104629
3.

Pancreatic ductal adenocarcinoma

(Submitter supplied) We sought to determine whether certain miRNAs could serve as a biomarker for the prognosis of pancreatic ductal adenocarcinoma (PDAC) and uncover the uncharacterized miRNAs function in the pancreatic carcinogenesis
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by array
Platform:
GPL18402
13 Samples
Download data: TXT
Series
Accession:
GSE109918
ID:
200109918
4.

Differentially expressed genes after siRNA transfection in human cancer cell lines

(Submitter supplied) To identify differentially expressed genes by anti cancer treatments (siRNAs) in human cancer, several cell lines (lung cancer, breast cancer and pancreatic cancer) were subjected to Agilent whole genome microarrays.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL20844
8 Samples
Download data: TXT
Series
Accession:
GSE115909
ID:
200115909
5.

Differentially expressed genes after miRNA or siRNA transfection in human cancer cell lines III

(Submitter supplied) To identify differentially expressed genes by anti cancer treatments (microRNAs or siRNAs) in human cancer, several cell lines ( pancreatic cancer, renal cell carcinoma, oral squamous cell carcinoma, prostate cancer and bladder cancer) were subjected to Agilent whole genome microarrays.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL20844
8 Samples
Download data: TXT
Series
Accession:
GSE115801
ID:
200115801
6.

Differentially expressed genes after miRNA or siRNA transfection in human cancer cell lines (III)

(Submitter supplied) To identify differentially expressed genes by anti cancer treatments (microRNAs or siRNAs) in human cancer, several cell lines (pancreatic cancer, esophageal cancer, tongue squamous cell carcinoma, hypopharyngeal squamous cell carcinoma and lung squamous cell carcinoma) were subjected to Agilent whole genome microarrays.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL20844
16 Samples
Download data: TXT
Series
Accession:
GSE82108
ID:
200082108
7.

Differentially expressed genes after miRNA or siRNA transfection in human cancer cell lines II

(Submitter supplied) To identify differentially expressed genes by anti cancer treatments (microRNAs or siRNAs) in human cancer, several cell lines (pancreatic cancer, esophageal cancer, bladder cancer, prostate cancer, renal cell carcinoma and lung squamous cell carcinoma) were subjected to Agilent whole genome microarrays.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL20844
32 Samples
Download data: TXT, XLSX
Series
Accession:
GSE77790
ID:
200077790
8.

MiRNA expression profiling in cholangiocarcinoma (CCA) cells compared to non-malignant human cholangiocyte

(Submitter supplied) Expression profiling of 2555 miRNAs was performed using microarray. Of these, 508 miRNAs expressed in both of CCA and non-malignant human cholangiocyte.
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by array
Platforms:
GPL21263 GPL18941
6 Samples
Download data: TXT
Series
Accession:
GSE121512
ID:
200121512
9.

Expression data in the human pancreatic cancer cell line RWP-1 subjected to SOX9 silencing

(Submitter supplied) The developmental transcription factor SOX9 exerts an oncogenic activity in pancreatic cancer. We used microarrays to detail the global programme of gene expression underlying the oncogenic activity of SOX9 in pancreatic cancer.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL16686
5 Samples
Download data: CEL, CHP
Series
Accession:
GSE193406
ID:
200193406
10.

The gene expression signatures of human normal, benign and PDAC pancreatic tisssues.

(Submitter supplied) To study the gene profile of 8 normal, 15 adjacent benign and 27 PDAC pancreatic tissues of human, data was generated with Agilent G2565CA arrays. Results provide a global profile of over 56,000 genes in human normal, benign and tumorous pancreatic tissues, and comparison of the differentially expressed genes among these 3 groups.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL22763
50 Samples
Download data: TXT
Series
Accession:
GSE91035
ID:
200091035
11.

YTHDF2 inhibits gastric cancer cell growth by regulating FOXC2 signaling pathway

(Submitter supplied) we found that YTHDF2 has lower expression in GC tissues and GC cells, and promotes the growth, migration and invasion of GC cells. In addition, the analysis of clinical data found that the expression level of YTHDF2 was closely related to the stage of GC and the survival of patients with GC. RNA-seq showed that overexpression of YTHDF2 significantly reduced protein expression in the FOXC2 (Forkhead box protein C2, FOXC2) signaling pathway.
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL24676
6 Samples
Download data: TXT
12.

Small RNA sequencing: EVs and the producing cells

(Submitter supplied) We report the high-throughput profiling of small RNA in extracellular vesicles (EVs) and their producing mammalian cells using Illumina small RNA sequencing platform. By obtaining over 2190 miRNA expression from 18 samples, the miRNA profile in EVs and their producing cells were compared. Results provide insight into gene profile difference between EV loading and the producing cells.
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by high throughput sequencing
Platform:
GPL16791
18 Samples
Download data: XLS
Series
Accession:
GSE99430
ID:
200099430
13.

SAMD1 suppresses epithelial-mesenchymal transition pathways in pancreatic ductal adenocarcinoma

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL21697
12 Samples
Download data: BW
Series
Accession:
GSE239418
ID:
200239418
14.

SAMD1 suppresses epithelial-mesenchymal transition pathways in pancreatic ductal adenocarcinoma [ChIP-Seq]

(Submitter supplied) Pancreatic ductal adenocarcinoma (PDAC) poses a significant threat due to its tendency to evade early detection, frequent metastasis, and the subsequent challenges in devising effective treatments. Processes that govern epithelial-mesenchymal transition (EMT) in PDAC hold promise for advancing novel therapeutic strategies. SAMD1 (SAM domain-containing protein 1) is a CpG island-binding protein that plays a pivotal role in the repression of its target genes. more...
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL21697
6 Samples
Download data: BW
Series
Accession:
GSE239415
ID:
200239415
15.

SAMD1 suppresses epithelial-mesenchymal transition pathways in pancreatic ductal adenocarcinoma [RNA-Seq]

(Submitter supplied) Pancreatic ductal adenocarcinoma (PDAC) poses a significant threat due to its tendency to evade early detection, frequent metastasis, and the subsequent challenges in devising effective treatments. Processes that govern epithelial-mesenchymal transition (EMT) in PDAC hold promise for advancing novel therapeutic strategies. SAMD1 (SAM domain-containing protein 1) is a CpG island-binding protein that plays a pivotal role in the repression of its target genes. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL21697
6 Samples
Download data: TXT
Series
Accession:
GSE239414
ID:
200239414
16.

MicroRNA expression data from leukemia and breast cancer cell lines with/without treatment with microparticles

(Submitter supplied) Microparticles (MPs) comprise the major source of systemic RNA including microRNA (miRNA), the aberrant expression of which appears to be associated with stage, progression and spread of many cancers. We have shown MPs to transfer multidrug resistance proteins accross both haematological and and non-haematological cancers. using microarray miRNA profiling analysis we now analyze changes in miRNA profiles of both cancer types following microparticle transfer. more...
Organism:
synthetic construct; Homo sapiens
Type:
Non-coding RNA profiling by array
Platform:
GPL8786
8 Samples
Download data: CEL
Series
Accession:
GSE34560
ID:
200034560
17.

TGF-beta-upregulated Lnc-Nr6a1 acts as a reservoir of miR-181 and mediates assembly of a glycolytic complex

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Mus musculus
Type:
Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL19057
12 Samples
Download data: BW
Series
Accession:
GSE207917
ID:
200207917
18.

TGF-beta-upregulated Lnc-Nr6a1 acts as a reservoir of miR-181 and mediates assembly of a glycolytic complex [ChIP-seq]

(Submitter supplied) Long noncoding RNAs (lncRNAs) have emerged as key regulators in a wide range of biological processes. The involvement of lncRNAs in epithelial-to-mesenchymal transition (EMT) has been well stablished; however, the role as immediate-early regulators is still unclear. Here, we identified a mouse miRNA-host gene lncRNA (lnc-Nr6a1) early upregulated during EMT. We show that this lncRNA is processed giving rise to abundant polyadenylated isoforms, lnc-Nr6a1 and lnc-Nr6a1-2, and a longer non-polyadenylated microprocessor-driven lnc-pri-miRNAS containing clustered pre-miRNA-181a2 and pre-miRNA-181b2 hairpins. more...
Organism:
Mus musculus
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL19057
4 Samples
Download data: BW
Series
Accession:
GSE207916
ID:
200207916
19.

TGF-beta-upregulated Lnc-Nr6a1 acts as a reservoir of miR-181 and mediates assembly of a glycolytic complex [RNA-seq]

(Submitter supplied) Long noncoding RNAs (lncRNAs) have emerged as key regulators in a wide range of biological processes. The involvement of lncRNAs in epithelial-to-mesenchymal transition (EMT) has been well stablished; however, the role as immediate-early regulators is still unclear. Here, we identified a mouse miRNA-host gene lncRNA (lnc-Nr6a1) early upregulated during EMT. We show that this lncRNA is processed giving rise to abundant polyadenylated isoforms, lnc-Nr6a1 and lnc-Nr6a1-2, and a longer non-polyadenylated microprocessor-driven lnc-pri-miRNAS containing clustered pre-miRNA-181a2 and pre-miRNA-181b2 hairpins. more...
Organism:
Mus musculus
Type:
Expression profiling by high throughput sequencing
Platform:
GPL19057
8 Samples
Download data: TXT
Series
Accession:
GSE207915
ID:
200207915
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=2|qty=4|blobid=MCID_670b10ea475a635e85d252de|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Support Center